Early Screen and Treatment for Gestational Diabetes

Status unconfirmed · Not applicable

Conditions studied: Gestational Diabetes

In brief

In the current study we aim to determine if early glucose screening and treatment among women at high risk for GDM improves perinatal outcome and decreases gestational weight gain. Half of the participant will be assigned to an early glucose screen group (12-18 weeks) and treatment if necessary and the other half to a standard 24-28 weeks glucose screen.

Key facts

Study ID
NCT02377531
Run by
University of South Florida
People needed
1020
Starts
2015-03-01
Expected to finish
2021-09-01
Last updated by the study team
2021-06-02

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.